| 000 | 01517 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513164105.0 | ||
| 264 | 0 | _c19990429 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(98)00161-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCoudeville, L | |
| 245 | 0 | 0 |
_aThe value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. _h[electronic resource] |
| 260 |
_bVaccine _cJan 1999 |
||
| 300 |
_a142-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aChickenpox _xeconomics |
| 650 | 0 | 4 |
_aChickenpox Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aData Collection |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMeasles Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aMeasles-Mumps-Rubella Vaccine |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMumps Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRubella Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 |
_aVaccines, Combined _xadministration & dosage |
| 700 | 1 | _aParee, F | |
| 700 | 1 | _aLebrun, T | |
| 700 | 1 | _aSailly, J | |
| 773 | 0 |
_tVaccine _gvol. 17 _gno. 2 _gp. 142-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(98)00161-3 _zAvailable from publisher's website |
| 999 |
_c9948560 _d9948560 |
||